Burrell Terry-Ann 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2023/7/14 申報
- 申報編號
- 0001209191-23-042305
- 申報時間
- 2023/7/14
- 交易日
- 2023/7/12-7/13
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $141.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Burrell Terry-AnnCIK 0001786484 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/7/12 | Class A Common Stock | S賣出處分 | −24,302 | $11.25F2 | −$273,397.5 | 147,545 | 直接 | |
| 2023/7/12 | Class A Common Stock | S賣出處分 | −78,071 | $12.15F3 | −$948,562.65 | 69,474 | 直接 | |
| 2023/7/12 | Class A Common Stock | S賣出處分 | −3,195 | $13.18F4 | −$42,110.1 | 66,279 | 直接 | |
| 2023/7/12 | Class A Common Stock | S賣出處分 | −3,157 | $14.08F5 | −$44,450.56 | 63,122 | 直接 | |
| 2023/7/13 | Class A Common Stock | S賣出處分 | −8,275 | $12.59F6 | −$104,182.25 | 54,847 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。